Literature DB >> 22127093

A decade of selective use of adjustable cutting seton combined with fistulotomy for anal fistula.

Allen Kamrava1, J Craig Collins.   

Abstract

Previous studies have demonstrated that the division of sphincter muscle in the treatment of anal fistula may precipitate fecal incontinence. Cutting setons may pose a particular risk of unrecoverable injury to the sphincter apparatus. To evaluate if the use of an adjustable cutting seton mitigates this risk, we performed a retrospective review of all patients operated on for anal fistulae in a 10-year period by a single surgeon. Adjustable cutting setons (consisting of heavy silk ligature with patient-controllable tension) were used selectively. Forty-seven patients met the study criteria. Ninety-four per cent of the fistulae treated were transsphincteric. All of the fistulae were treated with at least partial fistulotomy. Ninety-nine per cent of patients were followed to completion of treatment. One (2%) patient subsequently developed fecal incontinence, and four (9%) developed a recurrent or persistent fistula in the same location. Adjustable cutting setons have been used in our practice with a high success rate and low risk of complications. Our data support adjustable cutting setons as a useful tool in the surgeon's repertoire for treating fistulae that involve the anal sphincter complex.

Entities:  

Mesh:

Year:  2011        PMID: 22127093

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  3 in total

Review 1.  Management of Complex Anal Fistulas.

Authors:  Emily J Bubbers; Kyle G Cologne
Journal:  Clin Colon Rectal Surg       Date:  2016-03

2.  Evaluation of the cutting seton as a method of treatment for perianal fistula.

Authors:  Salah M Raslan; Mohammed Aladwani; Nasser Alsanea
Journal:  Ann Saudi Med       Date:  2016 May-Jun       Impact factor: 1.526

3.  The Value of Cutting Seton for High Transsphincteric Anal Fistula in the Era of Its Misery.

Authors:  Abdel Latif Khalifa Elnaim Ali; Michael Pak-Kai Wong; Ismail Sagap
Journal:  Malays J Med Sci       Date:  2022-02-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.